Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian L Dornan

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|April 5, 2018
Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-KinasesGillian L Dornan, John E Burke
Biochemical Society Transactions|February 11, 2016
Type III phosphatidylinositol 4 kinases: structure, function, regulation, signalling and involvement in diseaseGillian L Dornan, Jacob A McPhail, John E Burke
Journal of Molecular Biology|July 22, 2018
Probing the Architecture, Dynamics, and Inhibition of the PI4KIIIα/TTC7/FAM126 ComplexGillian L Dornan, Udit Dalwadi, David J Hamelin, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2017
Conformational disruption of PI3Kδ regulation by immunodeficiency mutations in <i>PIK3CD</i> and <i>PIK3R1</i>Gillian L Dornan, Braden D Siempelkamp, Meredith L Jenkins, et al.
Molecular Cell|June 7, 2014
The genetic and biochemical basis of FANCD2 monoubiquitinationEeson Rajendra, Vibe H Oestergaard, Frédéric Langevin, et al.
Structure (London, England : 1993)|December 14, 2019
Defining How Oncogenic and Developmental Mutations of PIK3R1 Alter the Regulation of Class IA Phosphoinositide 3-KinasesGillian L Dornan, Jordan T B Stariha, Manoj K Rathinaswamy, et al.
Elife|October 16, 2023
An unconventional gatekeeper mutation sensitizes inositol hexakisphosphate kinases to an allosteric inhibitorTim Aguirre, Gillian L Dornan, Sarah Hostachy, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2025
Influenza A virus NS1 protein mimics oncogenic PI3K resulting in isoform specific cellular redistribution and activationSadaf Aslam, María T Sánchez-Aparicio, Braden D Siempelkamp, et al.
Journal of Medicinal Chemistry|February 18, 2016
Design and Structural Characterization of Potent and Selective Inhibitors of Phosphatidylinositol 4 Kinase IIIβFlorentine U Rutaganira, Melissa L Fowler, Jacob A McPhail, et al.
Science (New York, N.Y.)|October 28, 2017
Architecture of eukaryotic mRNA 3'-end processing machineryAna Casañal, Ananthanarayanan Kumar, Chris H Hill, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|April 5, 2018
Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-KinasesGillian L Dornan, John E Burke
Biochemical Society Transactions|February 11, 2016
Type III phosphatidylinositol 4 kinases: structure, function, regulation, signalling and involvement in diseaseGillian L Dornan, Jacob A McPhail, John E Burke
Journal of Molecular Biology|July 22, 2018
Probing the Architecture, Dynamics, and Inhibition of the PI4KIIIα/TTC7/FAM126 ComplexGillian L Dornan, Udit Dalwadi, David J Hamelin, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2017
Conformational disruption of PI3Kδ regulation by immunodeficiency mutations in <i>PIK3CD</i> and <i>PIK3R1</i>Gillian L Dornan, Braden D Siempelkamp, Meredith L Jenkins, et al.
Molecular Cell|June 7, 2014
The genetic and biochemical basis of FANCD2 monoubiquitinationEeson Rajendra, Vibe H Oestergaard, Frédéric Langevin, et al.
Structure (London, England : 1993)|December 14, 2019
Defining How Oncogenic and Developmental Mutations of PIK3R1 Alter the Regulation of Class IA Phosphoinositide 3-KinasesGillian L Dornan, Jordan T B Stariha, Manoj K Rathinaswamy, et al.
Elife|October 16, 2023
An unconventional gatekeeper mutation sensitizes inositol hexakisphosphate kinases to an allosteric inhibitorTim Aguirre, Gillian L Dornan, Sarah Hostachy, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2025
Influenza A virus NS1 protein mimics oncogenic PI3K resulting in isoform specific cellular redistribution and activationSadaf Aslam, María T Sánchez-Aparicio, Braden D Siempelkamp, et al.
Journal of Medicinal Chemistry|February 18, 2016
Design and Structural Characterization of Potent and Selective Inhibitors of Phosphatidylinositol 4 Kinase IIIβFlorentine U Rutaganira, Melissa L Fowler, Jacob A McPhail, et al.
Science (New York, N.Y.)|October 28, 2017
Architecture of eukaryotic mRNA 3'-end processing machineryAna Casañal, Ananthanarayanan Kumar, Chris H Hill, et al.
Pageof 2